-
Oil turns lower, stocks gain on hopes of Hormuz opening
-
US hopeful Hormuz strait deal will be done 'today or tomorrow' after ship hit
-
World Bank warns developing countries to embrace AI or be left behind
-
Infantino's problems mount as Wenger and key FIFA ally turn on him
-
'No decision' on Mudryk future after Chelsea return: Alonso
-
Oil edges higher, stocks gain as investors eye political risks
-
China draws up safety rules for autonomous vehicles
-
Man Utd sign reported record £20mn sponsorship deal for training kit
-
Wenger says scrapping Infantino's World Cup plan was "absolutely necessary"
-
Stokes reveals England coaching ambition
-
Spain confronts EU migration hawks in tense Ceuta talks
-
Cargo ship hit after Trump insists Iran talks could reopen Hormuz today
-
Firefighters hope to contain blaze on Athens outskirts
-
BP profit soars as Mideast war roils energy prices
-
Heatwave divides rich and poor of upmarket Seoul
-
Most stock markets gain, while oil prices edge up after plunge
-
Drone strike on Moscow region kills 5
-
Most stock markets gain, while oil prices edge up after latest plunge
-
Guatemala issues 'danger' alert after Fuego volcano erupts
-
Weak yen helps auto giant Toyota raise forecasts
-
Heat kills 16 in South Korea this summer: interior ministry
-
TRON DAO Joins Blockchain Application Stanford Summit at the Science of Blockchain Conference as a Sponsor
-
Arson suspect arrested as US northwest battles wildfires
-
Rockets, Starlink, AI: SpaceX faces its first Wall Street grilling
-
Britain's Royal Mint strikes gold in electronic waste
-
After sparring over Ceuta, EU states seek lessons from crisis
-
Amorim evokes spirit of Baresi as he bids revive AC Milan fortunes
-
Forest fire spreads in Dutch nature reserve
-
Suspected heatstroke kills three lions at Japan zoo
-
Japan sees 'urgent' need to boost military
-
Stocks mixed as Seoul stabilises, oil prices rise with eyes on Mideast
-
Myanmar ex-junta chief set for first Thailand visit as civilian leader
-
Trapped by war, Bangladesh seafarer recounts Gulf ordeal
-
New Zealand hooker Bell out of South Africa tour with calf strain
-
WWII shells surface in wildfire-ravaged French village
-
Trump attorney general pick looks set to clear US Senate hurdle
-
Last Scottish island bird hunt banned after almost 500 years
-
MassRobotics Welcomes Analog Devices as Returning Strategic Sponsor to Power Next-Generation Robotics Startups
-
Arrive AI and LifeSpan Pharmacy Announce Letter of Intent to Explore Autonomous Drone Pharmacy Delivery Program
-
Mesothelioma Hope Interviews UNC Lineberger Oncologist Dr. Carrie Lee on Clinical Trials, Immunotherapy, and Maintaining Hope During Treatment
-
BREAKING NEWS: ELEKTROS Highlights Expanding Growth Strategy Amid Historic Market Momentum
-
phData and Snowflake Expand Strategic Collaboration to Help Enterprises Put AI Into Production
-
Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
-
TailorMed and RxSense Partner to Surface Manufacturer Copay Assistance Within Digital Pharmacy Marketplaces
-
James J. Carter Installed 84th President of the National Bar Association
-
Cubic Defense to Showcase Secure, Immersive Air Combat Training Capabilities for Naval Aviation at Hook '26
-
HOCHDORF Swiss Nutrition and Pharmalys Laboratories Announce Strategic Joint Venture to Accelerate Global Growth in Infant Nutrition, Backed by AS Equity Partners
-
WorkWorksUSA Expands Access to ACRE-Accredited Training for Supported Employment Providers Nationwide
-
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
-
Fast Finance Pay Corp. Advances Interoperability with WhatsApp Under the DMA Interoperability Framework Ahead of Q4 Rollout
Mesothelioma Hope Interviews UNC Lineberger Oncologist Dr. Carrie Lee on Clinical Trials, Immunotherapy, and Maintaining Hope During Treatment
The medical oncologist and Chief Medical Officer for Clinical Research at UNC Lineberger Comprehensive Cancer Center shares insights on tumor testing, multidisciplinary care, and why clinical trials shouldn't be viewed as a last resort.
CHESTNUT HILL, MA / ACCESS Newswire / August 4, 2026 / Mesothelioma Hope, a leading online resource providing education, patient advocacy, and support for those diagnosed with mesothelioma, has published a new interview with Dr. Carrie B. Lee, a medical oncologist and professor at the UNC School of Medicine who has spent more than two decades treating mesothelioma and lung cancer patients.
The full interview is available at MesotheliomaHope.com.
In the Q&A, Dr. Lee discusses how far mesothelioma treatment has come since she entered the field, when advanced-stage patients were considered essentially incurable. She points to the emergence of immunotherapy as a turning point, noting that some patients with advanced disease are now achieving remission and long-term survival - outcomes that were unthinkable a generation ago.
Key Takeaways From the Interview
Clinical Trials Aren't a Last Resort - Dr. Lee emphasized that clinical trials can be appropriate at the time of initial diagnosis, not just after other treatments are exhausted. She encouraged patients to ask their providers about trials early on and to contact patient advocacy organizations that can help match them with active studies.
Comprehensive Tumor Testing Matters - DNA and RNA sequencing can uncover genetic mutations that affect prognosis and open the door to targeted therapies or clinical trials that patients might not otherwise learn about.
Multidisciplinary Care Improves Outcomes - Dr. Lee described how medical oncologists, radiation oncologists, and surgeons collaborate on tumor boards to ensure that each patient's treatment plan reflects input from all relevant specialists.
Second Opinions From Specialty Centers - Because mesothelioma is rare, Dr. Lee recommends that patients seek at least one opinion from an academic cancer center experienced in treating the disease, even if ongoing care ultimately happens closer to home.
Redefining Hope During Treatment - Dr. Lee spoke candidly about how hope shifts depending on a patient's circumstances, from pursuing a cure in early-stage disease to prioritizing quality of life and comfort in more advanced cases.
"Even when the most serious circumstances arise, I never want to remove all hope," said Dr. Lee. "Sometimes things happen that we can't explain. The longer I do this, the more I realize that we're not in charge, and that we're here to love, help, and provide care and support for each other."
How Mesothelioma Hope Supports Patients
Mesothelioma Hope's Patient Advocates are available 24/7 to help patients and families:
Connect with mesothelioma specialists and academic cancer centers
Identify clinical trials that match a patient's diagnosis and treatment history
Access free educational guides covering treatment, prognosis, and legal options
Find support groups and financial assistance resources
A free 2026 Mesothelioma Guide is available at www.mesotheliomahope.com/mesothelioma-guide.
About Mesothelioma Hope
Mesothelioma Hope is a comprehensive patient support resource dedicated to helping individuals diagnosed with mesothelioma and their families access the information, specialists, and support they need. Through its team of Patient Advocates, the organization provides free guidance on treatment options, clinical trials, financial assistance, and legal resources. Mesothelioma Hope can be reached 24/7 by calling (866) 608-8933 or by visiting www.mesotheliomahope.com.
MEDIA CONTACT
Chris Carberg
(855) 346-6101
[email protected]
1330 Boylston St, Suite #400, Chestnut Hill, MA 02467
SOURCE: Mesothelioma Hope
View the original press release on ACCESS Newswire
G.Stevens--AMWN